- Home
- TOUR vs ADAG Comparison
TOUR vs ADAG Comparison
Compare TOUR & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOUR
- ADAG
- Stock Information
- Founded
- TOUR 2006
- ADAG 2011
- Country
- TOUR China
- ADAG China
- Employees
- TOUR N/A
- ADAG N/A
- Industry
- TOUR Transportation Services
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- TOUR Consumer Discretionary
- ADAG Health Care
- Exchange
- TOUR Nasdaq
- ADAG Nasdaq
- Market Cap
- TOUR 101.0M
- ADAG 91.4M
- IPO Year
- TOUR 2014
- ADAG 2021
- Fundamental
- Price
- TOUR $0.89
- ADAG $1.92
- Analyst Decision
- TOUR
- ADAG Strong Buy
- Analyst Count
- TOUR 0
- ADAG 1
- Target Price
- TOUR N/A
- ADAG $8.00
- AVG Volume (30 Days)
- TOUR 251.3K
- ADAG 51.3K
- Earning Date
- TOUR 08-05-2025
- ADAG 07-24-2025
- Dividend Yield
- TOUR 3.95%
- ADAG N/A
- EPS Growth
- TOUR N/A
- ADAG N/A
- EPS
- TOUR 0.07
- ADAG N/A
- Revenue
- TOUR $72,098,119.00
- ADAG $103,204.00
- Revenue This Year
- TOUR $16.99
- ADAG $6,488.89
- Revenue Next Year
- TOUR $13.23
- ADAG $57.50
- P/E Ratio
- TOUR $12.92
- ADAG N/A
- Revenue Growth
- TOUR 7.64
- ADAG N/A
- 52 Week Low
- TOUR $0.71
- ADAG $1.33
- 52 Week High
- TOUR $1.76
- ADAG $3.58
- Technical
- Relative Strength Index (RSI)
- TOUR 56.67
- ADAG 56.78
- Support Level
- TOUR $0.79
- ADAG $1.74
- Resistance Level
- TOUR $0.87
- ADAG $1.98
- Average True Range (ATR)
- TOUR 0.05
- ADAG 0.12
- MACD
- TOUR 0.01
- ADAG -0.00
- Stochastic Oscillator
- TOUR 100.00
- ADAG 72.22
About TOUR Tuniu Corporation
Tuniu Corp is an online leisure travel company. The company is engaged in the provision of travel-related services in the People's Republic of China. It offers a large selection of packaged tours, including organized tours and self-guided tours, as well as travel-related services for leisure travelers. The company's organized tours provide pre-arranged itineraries, transportation, accommodations, entertainment, meals, and tour guide services. Its self-guided tours consist of combinations of flights and hotel bookings and other optional add-ons. The company derives almost all of its revenue from PRC.
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.